[1]
2020. Evaluation of Safety of a Newly Formulated Pirfenidone in Chronic Kidney Disease: A Non-Randomized Pilot Study in Mexican Patients. Journal of Renal and Hepatic Disorders. 4, 1 (May 2020), 22–30. DOI:https://doi.org/10.15586/jrenhep.2020.61.